Sina Fellermeier-Kopf
Sina Fellermeier-Kopf publishes mostly in Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.
- World rank
- #4,554,189 of 7,710,434 ranked researchers
- Rank in Germany
- #231,789 of 364,343
- Works
- 16
- Citations
- 46
- Citations per work
- 2.9
What does Sina Fellermeier-Kopf research?
Sina Fellermeier-Kopf's work is mostly in Medicine (60%), Immunology and Microbiology (26%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1059.6%
- Medicine1059.6%
- Life Sciences636.2%
- Everything else14.2%
- 1Oncology30% of their works
- 2Immunology26% of their works
- 3Radiology, Nuclear Medicine and Imaging26% of their works
- 4Molecular Biology6% of their works
- 5Psychiatry and Mental health4% of their works
- 6Biotechnology4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Cancer Research and Treatments
- Cancer, Stress, Anesthesia, and Immune Response
- Radiopharmaceutical Chemistry and Applications
Which keywords describe Sina Fellermeier-Kopf's research?
The keywords of their largest research topics: Cancer Immunotherapy, Fc Receptors, Therapeutic Antibodies, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunotherapy, Tumor Regression and Dendritic Cells.
- Tumor Growth
- PET Imaging
- Bacterial Therapy
- NK Cell Recognition
- CAR T Cells
- Dendritic Cells
- Immunotherapy
- Immune Checkpoint Blockade
- Fc Receptors
- Cancer Immunotherapy
- Therapeutic Antibodies
- PD-1 and PD-L1
- Tumor Regression
- Immunity
- Chimeric Antigen Receptor
- Natural Killer Cells
- Chronic Stress
- Radiopharmaceuticals
- Tumor Targeting
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer Immunotherapy112 topics
- Fc Receptors101 topic
- Therapeutic Antibodies101 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- Immunotherapy72 topics
- Tumor Regression72 topics
- Dendritic Cells61 topic
- Immunity61 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- NK Cell Recognition31 topic
- Natural Killer Cells31 topic
- Bacterial Therapy21 topic
- Chronic Stress21 topic
- PET Imaging21 topic
- Radiopharmaceuticals21 topic
- Tumor Growth21 topic
- Tumor Targeting21 topic
Where does Sina Fellermeier-Kopf work?
Sina Fellermeier-Kopf's main affiliation in the publication record is BioNTech (Germany), Germany.
How many publications and citations does Sina Fellermeier-Kopf have?
OpenAlex counts 16 works and 46 citations for Sina Fellermeier-Kopf, an h-index of 3, ranking #4,554,189 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sina Fellermeier-Kopf. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.